A few days ago, Beijing Deputy Major Ding Xiangyang investigated and surveyed Beijing Haiyan Pharmaceutical Co., Ltd. of YRPG, which is located at Life Science Park of Zhongguancun of Changping District. The accompanying staff was as follows: Guan Chenghua, Secretary of District Committee of Changping District; Jin Shudong, District Mayor of Changping District; Cong Luoluo, Deputy Director General of Beijing food and Drug Administration; Wang Fuyi, Director General of Changping Sub-bureau of food and Drug Administration of Beijing; and leaders of Beijing Science and Technology Commission, Beijing Development and reform commission, Beijing Health Bureau, and Zhongguancun Science and Technology Park.
Established in 2005, Beijing Haiyan Pharmaceutical Co., Ltd. of YRPG is an integrated company focusing on drug R&D and combing drug production and marketing. Deputy Major Ding Xiangyang visited R&D and production departments of Haiyan Pharmaceutical and listened to the introduction, including Company profile, development prospect and challenges, made by Xu Jingren.
Deputy Major Ding Xiangyang highly spoke of the Company's achievements. He pointed out that following economic growth of China and the improvement of the health consciousness, China pharmaceutical industry is developing rapidly. As for the Company's difficulties and challenges in development, the government shall continuously strengthen the service functions, coordinate and solve the problems to help enterprise development and promote the economic development of Beijing. Meanwhile, it must be recognized that although the national overall situation on food and drug safety improves, food and drug safety events still happen occasionally. YRPG, as a leading enterprise in the pharmaceutical field, shall strengthen enterprise management to ensure the perfect product quality and safeguard the people's health and life safety.
Cong Luoluo, Deputy Director General of Beijing food and Drug Administration, indicated that the development of biological medicine was an important policy of Beijing. As the supervision department, Beijing Food and Drug Administration, while strengthening supervision work, would offer enterprises guide and service to help enterprises continuously improve their management level.